Replies

Is it possible to avoid heart damage from the COVID vaccine? Or do all COVID-vaccinated people have some myocarditis? - by ColleenHuberNMD - The Defeat Of COVID (substack.com)

Excerpt:
"At the time of this writing, in the current post-peak-COVID era, it has been 15 months since peak COVID mortality in the US and the world, which occurred in mid-April 2020, as shown by CDC data. [9]

Now, a year later, COVID vaccines have been aggressively introduced in most countries, and Our World In Data, which is funded by the Bill and Melinda Gates Foundation, estimates that 2.5 billion people or one quarter of the earth’s population, have already taken one of the new COVID vaccines, although they have only been available for about six months. [10]

As morbidity and mortality from SARS-CoV-2 and COVID-19 and its variants have diminished, and the world’s death rate per 1000 people is still at a relative low in 2020 and 2021 compared to the last seven decades, without evidence of any recent pandemic by mortality data, [11] we now can turn our attention to the health effects of the new COVID vaccines."

Fantastic article. This excerpt does a nice job of concisely explaining the science behind the Deep State's decision to prevent the public from accessing HCQ and Ivermectin.

Is it possible to avoid heart damage from the COVID vaccine? Or do all COVID-vaccinated people have some myocarditis? - by ColleenHuberNMD - The Defeat Of COVID (substack.com)

Excerpt:
The spike proteins that are generated by the mRNA COVID vaccines are said to be identical to those attached to SARS-CoV-2. [27]

The spike protein in SARS-CoV-2 is a trimeric, or three-part protein, composed of two functional S1 subunits, as well as a structural S2 subunit. Each of those three units are, incidentally, bound and inactivated by the drug ivermectin. [28]

In the absence of ivermectin or hydroxychloroquine, the two drugs most thoroughly studied and most widely used in early and late cases of COVID-19, [29] the spike protein remains in a conformation that enables it to attach to the ACE2 receptor on human cells, and to enter by that portal.

Conversely, either of those drugs are able to change the conformation of the spike protein in such a way that prevents entry to the human cell. [30]